Skip to main content

Pro-Dex, Inc.

corporate_fare Company Profile

Pro-Dex, Inc.

PDEX·NASDAQ·Industrial Applications And Services·CIK 0000788920

Pro-Dex, Inc. designs, develops, and manufactures autoclavable, battery-powered, and electric, multi-function surgical drivers and shavers. These products are primarily used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company utilizes patented adaptive torque-limiting technology and proprietary sealing solutions. Its primary customers are medical device distributors. Pro-Dex also offers engineering, quality, and regulatory consulting services. Additionally, it manufactures and sells rotary air motors to various industries, though these motors represent a de minimis portion of its business. Beginning in fiscal 2026, Pro-Dex expanded into selling precision machined parts and assemblies for the aerospace and defense industries through its newly acquired subsidiary, Advanced Precision Machining, LLC (APM). APM, located in Costa Mesa, California, manufactures some of Pro-Dex's machined sub-assemblies and also serves as a Prime Contractor for the U.S. Government, maintaining registrations under the International Traffic in Arms Regulations (ITAR) and a Joint Certification Program (JCP) certification. Pro-Dex was incorporated in Colorado in 1994. In August 2020, it formed PDEX Franklin, LLC, a wholly owned subsidiary, to hold title for an approximate 25,000 square foot industrial building in Tustin, California, acquired on November 6, 2020, to support business growth. PDEX Franklin has no separate operations. The company's principal headquarters are located at 2361 McGaw Avenue, Irvine, California 92614.

Pro-Dex, Inc. (NASDAQ:PDEX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for PDEX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for PDEX spans 10-Q, 8-K, 10-K, SCHEDULE 13D/A.

Recent high-impact activity:

  • Pro-Dex Q1 Sales Up 11% to $20.6M, Gross Margin 33%; Net Income Falls on Prior-Year Investment Gain
  • Pro-Dex Q1 Sales Rise 11% to $20.6M as Gross Margin Jumps to 33%
  • Pro-Dex Q4 Revenue Jumps 17% to $20.4M; Gross Margin Doubles to 35%
  • Pro-Dex Q4 Revenue Beats Estimates on Orthopedic Handpiece Sales
  • Pro-Dex FY2026 Net Income Jumps 52% to $13.7M; Cash Position Transforms to $8.2M

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$77.55M
Net Income
$13.66M
Diluted EPS
$4.12
Op. Cash Flow
$7.24M
Free Cash Flow
$6.76M
Gross Profit
$24.34M
Operating Income
$12.99M
Cash & Equivalents
$8.19M
Debt / Equity
0.00×
Net Margin
17.6%
Shares Outstanding
3.19M sh
Source: 10-K · filed 2026-09-03 · accession 0001079973-26-001215

Short Interest & Short Volume

7.42 days to cover

FINRA reported short interest of 271,336 shares in PDEX as of the October 30, 2026 settlement, a 15.0% increase from the prior period — about 7.4 days to cover at its recent average daily volume. On November 20, 2026, 57.8% of PDEX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)271,336 shares as of October 30, 2026
Change vs prior period▲ 15.0%
Days to cover7.42 at avg daily volume of 36,546
Daily short volume (FINRA facilities)57.8% of 15,869 shares on November 20, 2026
5-day average short volume65.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with P →
$64.1 +1.75% today
52-week range · as of 2026-10-29 $28.58 – $77
Market cap
$201.6M
Volume
53.9K (1.4× avg)
3-mo avg 39K
Live data · 2026-11-22 03:31 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PDEX - Latest Insights

PDEX
Oct 29, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $61.60
Real-time Price: $64.10 info
Change: +$2.50 (+4%) info
Market Cap: $201.6M info
PDEX
Oct 29, 2026, 4:00 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $61.25
Real-time Price: $64.10 info
Change: +$2.85 (+5%) info
Market Cap: $201.6M info
PDEX
Sep 03, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $64.10 info
Change: -$0.900 (-1%) info
Market Cap: $201.6M info
PDEX
Sep 03, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $64.10 info
Change: -$0.900 (-1%) info
Market Cap: $201.6M info
PDEX
Sep 03, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $64.10 info
Change: -$0.900 (-1%) info
Market Cap: $201.6M info
PDEX
Jun 26, 2026, 5:59 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $61.47
Real-time Price: $64.10 info
Change: +$2.63 (+4%) info
Market Cap: $201.6M info
PDEX
Apr 30, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $50.14
Real-time Price: $64.10 info
Change: +$13.96 (+28%) info
Market Cap: $201.6M info
PDEX
Apr 30, 2026, 4:00 PM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $50.14
Real-time Price: $64.10 info
Change: +$13.96 (+28%) info
Market Cap: $201.6M info
PDEX
Feb 12, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $38.09
Real-time Price: $64.10 info
Change: +$26.01 (+68%) info
Market Cap: $201.6M info
PDEX
Jan 29, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $39.41
Real-time Price: $64.10 info
Change: +$24.69 (+63%) info
Market Cap: $201.6M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets